NEWSROOM

medical

UAT Group Strategic Partner NextCast Receives Patent Approval

  Tampa, FL, Oct. 18, 2021 -- McapMediaWire -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (“UAT Group”) announced today that strategic partner Next Casting Technologies has received its Notice of Allowance from the United States Patent Office, paving the way for its advanced SmartCast, IntelliBrace and BioSplint technology to enter into patented production. UAT Chief Executive Officer Alex Umbra, stated, “The NextCast SmartCast system has been under development and testing for...

read more

AVRA Medical Robotics, Inc. Appoints Dr. Onur Toker to Accelerate Development of its Surgical Robotic System

  ORLANDO, FL, June 28, 2021 - McapMediaWire - AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC Pink: AVMR) today announces the appointment of Dr. Onur Toker, a leading expert in electrical and computer engineering, as Senior Design Engineer to accelerate the development of its advanced surgical robotic system. Dr. Toker joins AVRA from Florida Poly, where he is an associate professor in electrical and computer engineering focusing on hardware acceleration, field-programmable...

read more

HUMAN UNITEC INTERNATIONAL INC ANNOUNCES STRATEGIC ACQUISITION OF SUBTANTIAL SHARES OF VENTIAN CLUSTER

    Boston, Massachusetts, June 15, 2021 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) ("HMNU"), is a Project Finance, Management & Development for Sustainability, Medical, Wellness, and Green Energy, announces a strategic acquisition of substantial shares in Venetian Cluster, SRL., https://www.venetiancluster.eu/it/ Venetian Cluster is the only productive cluster of environmental and cultural heritage in Italy. Its main target is to realize national and...

read more

SUPRVA HEALTHCARE GROUP, INC. PLANS TO ACQUIRE MEDICAL OFFICE BUILDING IN CALIFORNIA

  Liverpool, New York, June 11, 2021 - McapMediaWire - Supurva Healthcare Group, Inc. (OTC Pink: SPRV) (the “Company”) announced today that it has signed a Letter of Intent to acquire a Medical Office Building (“MOB”) in Northern California. John D. Murphy Jr., the Company’s CEO stated that the majority of the medical office building is leased to a credit-rated health system that has increased its occupancy in the building over the past twenty years.  All the tenants have annual...

read more

SUPURVA HEALTHCARE GROUP, INC. ADVOCATES MEDICAL REAL ESTATE AS AN EFFECTIVE HEDGE AGAINST INFLATION

  Liverpool, New York, May 27, 2021 - McapMediaWire - Supurva Healthcare Group, Inc. (OTC Pink: SPRV) (“SPRV”) (the “Company”) announced today that John Murphy President and CEO recently stated that macroeconomic trends that include the Government's COVID -19 stimulus packages, reduced unemployment, and increases in GDP, strongly indicate inflation is on the horizon in the United States. Historical empirical evidence supports real estate as an effective hedge against inflation, as rents...

read more

AVRA Medical Robotics’ Chief Medical Officer to Reveal Company’s Latest Developments in Surgical Robots at Global Conference

  ORLANDO, FL, May 26, 2021 - McapMediaWire - AVRA Medical Robotics, Inc. (OTC Pink: AVMR) (“AVRA” or “the Company”) today announces that its Chief Medical Officer, Farhan Taghizadeh, MD will reveal the latest developments in the field of digital surgery at the prestigious 13th 5CC World Congress to be held virtually in Barcelona this September 2021. Dr. Taghizadeh is currently working with the Avra engineering group in the design and development of one of the world’s most sophisticated...

read more

HUMAN UNITEC INTERNATIONAL INC ANNOUNCES STRATEGIC ACQUISITION OF SUBTANTIAL SHARES OF LAKEN GROUP, LTD., AND THE PROPERTY BLOCKCHAIN TRADE TOKEN COLLATERIZED WITH REAL ESTATE ASSETS

  Boston, Massachusetts, May 25, 2021 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) ("HMNU"), announces a strategic acquisition of substantial shares in Laken Group Ltd, UK, "Laken Group", https://lakengroup.com/,  a Blockchain and Cryptocurrency company based in London, England since 2020. - Laken Group, Ltd. is the founder of Blockchainpropertytrade, https://www.blockchainpropertytrade.com/.   Blockchainpropertytrade has authorized 10 Billions PBT tokens as...

read more

CORPORATE UPDATE ON HUMAN UNITEC INTERNATIONAL, INC. (HMNU)

  Boston, Massachusetts, May 18, 2021 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) (“HMNU”), announces a strategic joint venture distribution and marketing agreement with Periso, CH, “PERISO”, https://periso.ch/ , a Swiss based company since 1962. The terms of the agreement require HMNU to contribute the first financial of Four Million Five Hundred Thousand Dollars, ($4,500,000), on or before June 30, 2021. HMNU President, Fabrizio Bosticco, states: “This agreement...

read more

Gold River Productions, Inc. (GRPS) announces its initial product line for physicians and its newly-initiated physician-patient distribution network

  Palm Coast, FL, April 5, 2021, Gold River Productions, Inc. (OTC Pink: GRPS) announces today its initial product line for physicians and its newly-initiated physician-patient distribution network. With RushNet Inc.'s (OTC Pink: RSHN) recent acquisition of HeliosDX, the Company isfortunate to share an expanding network of physicians through whom they will be marketing most of their products. Its new CEO, Ashley Sweat, said “I look forward to introducing these products to the HeliosDx...

read more

Chattahoochee Labs/HeliosDx announces the acquisition of control of a public entity, RushNet Inc. (OTC US: RSHN) and has filed with the State of Colorado

Alpharetta, Ga. March 30, 2021 - - Chattahoochee Labs/HeliosDx has taken a major step forward in achieving its goal of robust and profitable expansion as well as adding exceptional value to its shareholders and announces the acquisition of public entity RushNet, Inc (OTC Pink: RSHN). Having enjoyed rapid growth in revenues from 1.7 million dollars in 2018 to 2.6 million dollars in 2019, 4.3 million dollars with an adjusted EBITDA of 1.3 million in 2020, and an expected 6 million dollars in...

read more

UAT Group Inc, Acquires 20% of Next Casting Technologies

  Tampa FL, March 4th,2021 - - Umbra Applied Technologies Group, Inc (OTC Pink: UATG) announced today that it has purchased 20% of the Austin, Texas based medical company Next Casting Technologies. The global orthopedic casting, splinting, braces and support market was valued at US $4.6 billion in 2015 and is expected to reach US $7.9 billion by 2024, at a CAGR of 6.4%. Next Casting Technologies has projected its first-year revenues to be $16.1M once it launches with a five-year...

read more

PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021

Sandusky, OH, January 12, 2021 – -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts, Inc. (OTC PINK: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD) derived from a patented...

read more

PAOG Takes Major CBD Pharmaceutical Development Step Forward

  Sandusky, OH, January 5, 2021 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced a major step forward in the development of a CBD pharmaceutical product. PAOG today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.  PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward initiating an...

read more

RENAVOTIO, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2020

Tulsa, OK, November 17, 2020 – -- Renavotio, Inc (OTC US: RIII), (“Renavotio,” or the “Company”) today announced its recently-filed unaudited financial results for the third quarter ended September 30, 2020. For further information, please refer to the Company’s recently-filed 10Q on EDGAR. Revenue– Due to a new focus on domestic U.S. business opportunities, coupled with the declining overseas revenues from the COVID-19 pandemic’s economic impact,  Renavotio has decided to close its overseas...

read more

Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt

Nutra Pharma is providing updates regarding debt restructuring and financing plans   Plantation, Florida, November 4, 2020 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their plans and progress involving financing,...

read more

PAOG Advances Nutraceutical Development From Its Cannabis Pharmaceutical Research

Sandusky, OH, October 29, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced adding a nutraceutical development pathway to its existing pharmaceutical cannabis drug development strategy.  Last week, PAOG announced a master services agreement with a clinical research organization (CRO) in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA).  More details on the CRO contract are coming soon.  Now PAOG has...

read more

PAOG Targets Spring Launch Of Hemp Cultivar Facility

Sandusky, OH – October 13, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed an agreement with Puration, Inc. (OTC PINK: PURA) to build a proprietary hemp cultivar development facility on PURA’s Farmersville, Texas branded site and announced an April 2021 target date for construction to be completed. PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company’s overall...

read more

PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech To Prepare RespRx For IND

Sandusky, OH – October 1, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced engaging Saul Kaye the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG’s RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RexpRx for engaging with a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA)....

read more

PAOG Target CBD Pharma Development In Puerto Rico Could Get Boost From COVID-19

Sandusky, OH – Sep 17, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today highlighted recent increased interest in the resurgence of industry-wide Pharmaceutical research and manufacturing in Puerto Rico. PAOG is currently in discussions in to engage a Contract Research Organization (CRO) in Puerto Rico to advance an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for PAOG’s RespRx as a COPD treatment. The COPD treatment, RespRx, is...

read more

PAOG Announces Agreement To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site

Sandusky, OH – September 16, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced an agreement with Puration, Inc. (OTC PINK: PURA) to build a proprietary hemp cultivar development facility on PURA’s Farmersville, Texas branded site.    PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company’s overall pharmaceutical focus. PAOG is developing a hemp-derived cannabidiol...

read more

PAOG Goes Global With CBD Pharmaceutical Research To Target $5.8 Billion Market

Sandusky, OH – Sep 15, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) Announces a multifold, international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”  In an initial scientific evaluation as...

read more

PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published Today

Sandusky, OH – September 8, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced Goldman Small Cap Research has published an analyst research report update.  PAOG has recently entered the cannabis biopharmaceutical sector through two recent acquisitions.  The company acquired a cannabis cultivation business from Puration, Inc. (PURA). From Kali-Extracts (KALY), PAOG acquired a proprietary CBD extract derived from a patented extraction process and formulated for the treatment of...

read more

PAOG Announces Goldman Small Cap Research Update Scheduled Next Week

Sandusky, OH – September 2, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced an analyst research report update form Goldman Small Cap Research scheduled to be published next week on Tuesday, September 8, 2020. The original Goldman Small Cap Research Update can be reviewed at: Under The Radar CBD Pharma Player Could Offer Major Upside PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the cannabis biopharmaceutical...

read more

Forwardly, Inc. Raises $500,000 Privately; Will Fund Development of Ligand Global Innovation’s Latest Prototype of LifeAir G1

Boulder City, NV, August 31, 2020 – -- George Sharp, President and CEO of Forwardly, Inc. (OTC PINK: FORW), announced today that it has already received funding commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Global Innovation’s (“Ligand”) development of its latest prototype of the LifeAir G1 Portable Ventilator. As announced in a June 15, 2020 press release, Forwardly, through its wholly-owned subsidiary, Breathe Medical Devices, Inc.,...

read more

PAOG Completes Compliance Updates In Conjunction With Cannabis Biopharma Revitalization Initiative

Sandusky, OH – August 27, 2020 –  -- PAO Group, Inc. (OTC PINK: PAOG) today announced having published all required filings necessary to meet the OTC Markets “Current Information” reporting standard. Yesterday, the company published the final compliance requirement, a legal opinion, following the publications of its Q1 2020 and Q2 2020 report earlier this week and the 2019 annual report published late last week.  The company anticipates the “Current Information” status to soon be reflected on...

read more

PAOG Files Q1 2020 and Q2 2020 Reports Moving Closer To Current Info Status

Sandusky, OH – August 25, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced filing its Q1 2020 and Q2 2020 reports after yesterday announcing the filing of its 2019 annual report. PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company’s financial statements to make the company compliant with the OTC Markets’ “Current Information”...

read more

PAOG Files 2019 Annual Report In Conjunction With CBD Biopharma Revitalization

Sandusky, OH – August 24, 2020 -- PAO Group, Inc. (OTC PINK: PAOG) today announced filing its 2019 annual report and expects to soon have all its public disclosures in compliance with OTC Markets “Current Information” reporting standard. PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company’s financial statements to make the company...

read more

PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions

Sandusky, OH – August 21, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) confirmed today that the company expects to soon have its public disclosures in compliance with OTC Markets “Current Information” reporting standard.  The efforts underway are expected to see the company back in compliance no later than by the end of this month. PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector.  The...

read more

PAOG Explores Cannabis Respiratory Research Partnership In Israel

Sandusky, OH – August 14, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced the company is aggressively pursuing international research partnerships to advance its cannabis respiratory treatment development. The company recently revealed research partnership developments in Puerto Rico where Congresswoman Jenniffer González Colón and Florida Senator Marco Rubio recently introduced legislation to position Puerto Rico as a global production center of medical equipment and drugs. Israel...

read more

Categories

Mcap MediaWire - Costumer Service